These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The efficacy of various treatment modalities on aluminium associated bone disease. Ihle BU; Buchanan MR; Stevens B; Becker GJ; Kincaid-Smith P Proc Eur Dial Transplant Assoc; 1983; 19():195-202. PubMed ID: 6348735 [TBL] [Abstract][Full Text] [Related]
7. [Treatment of aluminum-induced osteopathy with desferrioxamine in dialysis-dependent renal failure]. Lechleitner P; Gmeiner R; Beck G; König P Wien Med Wochenschr; 1987 Aug; 137(14-15):355-60. PubMed ID: 3673100 [TBL] [Abstract][Full Text] [Related]
9. The use of intravenous and intraperitoneal desferrioxamine in aluminium osteomalacia. O'Brien AA; McParland C; Keogh JA Nephrol Dial Transplant; 1987; 2(2):117-9. PubMed ID: 3112649 [TBL] [Abstract][Full Text] [Related]
10. Clinical and biochemical features of aluminum-related bone disease. Ihle BU; Becker GJ; Kincaid-Smith PS Kidney Int Suppl; 1986 Feb; 18():S80-6. PubMed ID: 3458003 [No Abstract] [Full Text] [Related]
11. Aluminum intoxication of bone in renal failure--fact or fiction? Malluche HH; Faugere MC; Smith AJ; Friedler RM Kidney Int Suppl; 1986 Feb; 18():S70-3. PubMed ID: 3458000 [No Abstract] [Full Text] [Related]
12. Combined hemofiltration and desferrioxamine treatment for aluminum induced osteomalacia. Barré PE; Prichard S Int J Artif Organs; 1986 May; 9(3):167-72. PubMed ID: 3733242 [TBL] [Abstract][Full Text] [Related]
13. Changes in bone histology after treatment with desferrioxamine. Ott SM; Andress DL; Nebeker HG; Milliner DS; Maloney NA; Coburn JW; Sherrard DJ Kidney Int Suppl; 1986 Feb; 18():S108-13. PubMed ID: 3457986 [No Abstract] [Full Text] [Related]
14. Clearance of aluminum by hemodialysis: effect of desferrioxamine. Milliner DS; Hercz G; Miller JH; Shinaberger JH; Nissenson AR; Coburn JW Kidney Int Suppl; 1986 Feb; 18():S100-3. PubMed ID: 3457984 [No Abstract] [Full Text] [Related]
15. Fracture healing with deferoxamine therapy in a patient with aluminum-associated osteomalacia. Phelps KR; Einhorn TA; Vigorita VJ; Lundin AP; Friedman EA ASAIO Trans; 1986; 32(1):198-200. PubMed ID: 3778712 [No Abstract] [Full Text] [Related]
16. Hypercalcaemic osteomalacia and encephalopathy due to aluminium intoxication in haemodialysis patients. Clinical aspects and treatment with desferrioxamine. Mudde AH; Roodvoets AP; Van Groningen K Neth J Med; 1985; 28(1):6-11. PubMed ID: 3974771 [No Abstract] [Full Text] [Related]
17. Healing of fracturing-bone disease occurring in patients on dialysis. A prospective study. Milne FJ; Hudson GA; Meyers AM; Baily P; Barmeir E; Dubowitz B; Reis P S Afr Med J; 1982 Jun; 61(25):955-9. PubMed ID: 7089762 [TBL] [Abstract][Full Text] [Related]
18. Differential diagnosis between secondary hyperparathyroidism and aluminum intoxication in uremic patients: usefulness of 99mTc-pyrophosphate bone scintigraphy. Kinnaert P; Van Hooff I; Schoutens A; Bergmann P; Fuss M; Dratwa M; Vienne A; Pasteels JL; van Geertruyden J; Vanherweghem JL World J Surg; 1989; 13(2):219-23; discussion 223-4. PubMed ID: 2543146 [TBL] [Abstract][Full Text] [Related]
19. [Detecting and evaluating hyperaluminemia in 3 dialysis centers]. Balabán D; Simícková J; Kubátko J; Syrovátka P Cas Lek Cesk; 1989 Dec; 128(51):1611-4. PubMed ID: 2631999 [TBL] [Abstract][Full Text] [Related]
20. Case report 288: osteomalacia and secondary hyperparathyroidism (dialysis-induced), with aluminum deposition. Llewellyn CH; Resnik CS; Brower AC Skeletal Radiol; 1984; 12(3):223-6. PubMed ID: 6494942 [No Abstract] [Full Text] [Related] [Next] [New Search]